## **Core Concept**
Thalassemia major, also known as beta-thalassemia major or Cooley's anemia, is a severe form of thalassemia that results from mutations in both alleles of the beta-globin gene. This leads to a significant reduction or absence of beta-globin chain production, causing an imbalance in globin chain synthesis. The condition is characterized by severe anemia, growth retardation, and various complications due to iron overload.

## **Why the Correct Answer is Right**
The correct answer, . (splenomegaly), is indeed a feature commonly seen in thalassemia major. However, to address the question, we need to evaluate each option in the context of thalassemia major.

## **Why Each Wrong Option is Incorrect**
- **Option A:** . (severe microcytic hypochromic anemia) - This is a hallmark of thalassemia major due to the ineffective erythropoiesis and the presence of a significant number of microcytic, hypochromic red blood cells.
- **Option B:** . (growth retardation) - Growth retardation is indeed seen in thalassemia major, partly due to chronic anemia, iron overload, and the effects of chelation therapy.
- **Option C:** . (skeletal changes) - Skeletal changes, including bone deformities and expansion of bone marrow spaces, are common due to the marrow expansion that occurs in response to ineffective erythropoiesis.

## **Why . (Target Cells) is the Correct Answer**
Target cells are more characteristically associated with hemoglobinopathies like sickle cell disease and hereditary spherocytosis rather than being a defining feature of thalassemia major. While they can occasionally be seen, the primary red cell morphology in thalassemia major is microcytic and hypochromic.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl in thalassemia major is the importance of regular blood transfusions and iron chelation therapy to prevent complications from iron overload, such as cardiac and liver dysfunction.

## **Correct Answer: .**